Therapeutic drug monitoring of aminoglycosides in neonates (Q37409465)

20 August 2017

1 reference

title

Therapeutic drug monitoring of aminoglycosides in neonates. (English)

1 reference

20 August 2017

Daniël J Touw

1

1 reference

20 August 2017

Elsbeth M Westerman

series ordinal

2

1 reference

20 August 2017

Arwen J Sprij

series ordinal

3

1 reference

20 August 2017

1 January 2009

1 reference

Clinical Pharmacokinetics

20 August 2017

1 reference

20 August 2017

48

1 reference

20 August 2017

2

1 reference

20 August 2017

71-88

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200948020-00001

20 August 2017

0 references

cites work

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200948020-00001

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200948020-00001

First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200948020-00001

Aminoglycoside-induced hearing loss in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200948020-00001

Gentamicin blood levels: a guide to nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200948020-00001

Prospective Comparative Study of Variable Dosage and Variable Frequency Regimens for Administration of Gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200948020-00001

Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200948020-00001

Pharmacokinetics of gentamicin in neonates on extracorporeal membrane oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200948020-00001

Gentamicin population pharmacokinetic models for low birth weight infants using a new nonparametric method

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200948020-00001

Amikacin pharmacokinetics and suggested dosage modifications for the preterm infant

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200948020-00001

Pharmacokinetic Properties of Netilmicin in Newborn Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200948020-00001

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200948020-00001

Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

21 January 2018

1 reference

12 December 2020

The kinetic profile of gentamicin in premature neonates.

1 reference

12 December 2020

Potential benefit of Bayesian forecasting for therapeutic drug monitoring in neonates

1 reference

12 December 2020

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

1 reference

12 December 2020

Aminoglycosides: nephrotoxicity

1 reference

12 December 2020

Aminoglycoside and vancomycin serum concentration monitoring and mortality due to neonatal sepsis in Saudi Arabia.

1 reference

12 December 2020

Epidemiology of neonatal group B streptococcal disease in The Netherlands 1997-98.

1 reference

12 December 2020

Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates.

1 reference

12 December 2020

Aminoglycoside dosages and nephrotoxicity: quantitative relationships

1 reference

12 December 2020

Renal drug clearance in preterm neonates: relation to prenatal growth

1 reference

12 December 2020

Drug disposition in neonates with patent ductus arteriosus

1 reference

12 December 2020

Extended-interval aminoglycoside administration for children: a meta-analysis

1 reference

12 December 2020

Monitoring serum levels of gentamicin to develop a new regimen for gentamicin dosage in newborns

1 reference

12 December 2020

Individualising gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring strategies

1 reference

12 December 2020

Bayesian pharmacokinetic analysis of a gentamicin nomogram in neonates: a retrospective study

1 reference

12 December 2020

Population kinetics of tobramycin in neonates

1 reference

12 December 2020

Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia

1 reference

12 December 2020

Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy.

1 reference

12 December 2020

Aminoglycosides: activity and resistance

1 reference

12 December 2020

Interindividual variability of aminoglycoside pharmacokinetics in preterm neonates at birth

1 reference

12 December 2020

Limited predictability of amikacin clearance in extreme premature neonates at birth

1 reference

12 December 2020

Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?

1 reference

12 December 2020

Clinical pharmacokinetics of antibacterial drugs in neonates

1 reference

12 December 2020

Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis

1 reference

12 December 2020

An extended interval dosing method for gentamicin in neonates

1 reference

12 December 2020

Population pharmacokinetic models: effect of explicit versus assumed constant serum concentration assay error patterns upon parameter values of gentamicin in infants on and off extracorporeal membrane oxygenation.

1 reference

12 December 2020

Gentamicin dosing in neonatal patients

1 reference

12 December 2020

In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats.

1 reference

12 December 2020

Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss

1 reference

12 December 2020

Altered NMDA receptor expression in renal toxicity: Protection with a receptor antagonist

1 reference

12 December 2020

Population pharmacokinetics of gentamicin in premature newborns.

1 reference

12 December 2020

Newborns and gentamicin--how much and how often?

1 reference

12 December 2020

Pharmacokinetics and renal function in preterm infants

1 reference

12 December 2020

Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis

1 reference

12 December 2020

Gentamicin pharmacokinetics in preterm infants with a patent and a closed ductus arteriosus

1 reference

12 December 2020

Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis

1 reference

12 December 2020

Tobramycin population pharmacokinetics in neonates.

1 reference

12 December 2020

NONMEM and NPEM2 population modeling: a comparison using tobramycin data in neonates

1 reference

12 December 2020

Therapeutic drug monitoring principles in the neonate. National Academy of CLinical Biochemistry.

1 reference

12 December 2020

Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates

1 reference

12 December 2020

Population pharmacokinetics of gentamicin in premature infants

1 reference

12 December 2020

Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.

1 reference

12 December 2020

Are vestibular hair cells excited to death by aminoglycoside antibiotics?

1 reference

12 December 2020

Gentamicin pharmacokinetics in neonates with patent ductus arteriosus

1 reference

12 December 2020

Changes in gentamicin serum levels and pharmacokinetic parameters in the newborn in the course of treatment with aminoglycoside

1 reference

12 December 2020

Population pharmacokinetics of gentamicin in neonates using a nonlinear, mixed-effects model

1 reference

12 December 2020

Once-daily gentamicin dosing in newborn infants

1 reference

12 December 2020

Population pharmacokinetic analysis of netilmicin in neonates and infants with use of a nonparametric method.

1 reference

12 December 2020

Population pharmacokinetics of gentamicin in preterm neonates: evaluation of a once-daily dosage regimen

1 reference

12 December 2020

Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring

1 reference

12 December 2020

Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control

1 reference

12 December 2020

Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation

1 reference

12 December 2020

Optimal sampling times for pharmacokinetic experiments

1 reference

12 December 2020

10.2165/00003088-200948020-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

20 August 2017

0 references

1 reference